TY - JOUR AU - Tsuda, Moe AU - Toi, Masakazu PY - 2018 TI - Duloxetine for AI-associated joint pain in breast cancer patients JF - Translational Cancer Research; Vol 7, Supplement 4 (April 26, 2018): Translational Cancer Research Y2 - 2018 KW - N2 - Aromatase inhibitors (AIs) are the standard of care for treatment of both early and advanced hormone-sensitive breast cancer in postmenopausal women. Although AIs have been considered to be well-tolerated, only 50 % of patients can complete the full course of the treatment, at the optimal schedule (1). UR - https://tcr.amegroups.org/article/view/20388